The Oxford-AstraZeneca jab, though initially less effective, offers the same high protection as the Pfizer-BioNTech after four to five months, the largest study of its kind suggests. BBC News
See also:
- Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK (open access) Nuffield Department of Medicine
- Covid vaccine: US plans to offer booster Covid jabs in September BBC News
- UK's Covid cases rise again with 33,904 positive tests, marking a 15% week-on-week jump The Daily Mail
- Double-jabbed who catch Delta variant are just as likely to spread Covid as the unvaccinated The Daily Mail
- Covid hospital patient numbers hit five-month high in England The Independent
- NHS worker who died with Covid was refused shielding status despite history of respiratory problems ITV News
No comments:
Post a Comment